| Elovl6 promotes nonalcoholic steatohepatitis | Hepatology | 2012 | 120 |
| Diagnosis and management of type I and type V hyperlipoproteinemia | Journal of Atherosclerosis and Thrombosis | 2012 | 65 |
| Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD | American Journal of Physiology - Endocrinology and Metabolism | 2012 | 37 |
| Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout | Progress in Lipid Research | 2012 | 35 |
| Impact of psychological stress caused by the Great East Japan Earthquake on glycemic control in patients with diabetes | Experimental and Clinical Endocrinology and Diabetes | 2012 | 32 |
| Fasting insulin levels and metabolic risk factors in type 2 diabetic patients at the first visit in Japan: a 10-year, nationwide, observational study (JDDM 28) | Diabetes Care | 2012 | 18 |
| Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways | American Journal of Physiology - Endocrinology and Metabolism | 2012 | 16 |
| Dicer has a crucial role in the early stage of adipocyte differentiation, but not in lipid synthesis, in 3T3-L1 cells | Biochemical and Biophysical Research Communications | 2012 | 13 |
| Management of type IIb dyslipidemia | Journal of Atherosclerosis and Thrombosis | 2012 | 12 |
| Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma | Clinical Endocrinology | 2012 | 11 |
| Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: the Toranomon Hospital Health Management Center Study 2 (TOPICS 2) | Diabetes Research and Clinical Practice | 2012 | 9 |
| A case of acute adrenal insufficiency unmasked during sunitinib treatment for metastatic renal cell carcinoma | Japanese Journal of Clinical Oncology | 2012 | 7 |
| GLUT12: a second insulin-responsive glucose transporters as an emerging target for type 2 diabetes | Journal of Diabetes Investigation | 2012 | 5 |
| Background to discuss guidelines for control of plasma HDL-cholesterol in Japan | Journal of Atherosclerosis and Thrombosis | 2012 | 3 |
